Clinical Trial Update: Combination Therapy for the Treatment of Diffuse Midline Gliomas [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes a combination therapy for diffuse midline gliomas, including H3 K27M-mutant DMG and DIPG, with the study currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Diffuse Midline Glioma H3 K27m-mutant
• Who Grade Iii Glioma

Snippet

Sponsor: University of California, San Francisco | Conditions: Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant | Phase 2 | Status: RECRUITING